• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管假体的补体激活及其在动脉粥样硬化病变进展中的作用。

Complement activation by vascular prostheses and its role in progression of arteriosclerotic lesions.

作者信息

Miyauchi M, Shionoya S

机构信息

First Department of Surgery, Nagoya University School of Medicine, Japan.

出版信息

Angiology. 1988 Oct;39(10):881-90. doi: 10.1177/000331978803901005.

DOI:10.1177/000331978803901005
PMID:3263065
Abstract

This study, using C3a, C4a, and C5a assay and crossed immunoelectrophoresis in vitro and in vivo, was designed to determine whether vascular prostheses activate the complement system. The degree of complement activation and the pathway of activation were also studied. The complement levels (C3, C4, CH50) in different arterial diseases were measured, and the relationship of complement levels to serum lipids in patients with arteriosclerosis obliterans (ASO) was also investigated, in order to clarify a relationship between the complement system and arteriosclerosis or other arterial diseases. Bovine graft, dacron, and PTFE activated the complement system in vitro. In order of the degree of complement activation, bovine graft ranked first, followed by dacron and PTFE. The patient group with acute arterial occlusion showed high C3 and C4 levels. The healthy elderly group showed higher C3 and C4 levels than the healthy persons in their twenties. In ASO patients, C3 levels correlated with serum lipid levels. Judged from the relation of complement activation by vascular prostheses to the progression of arteriosclerotic changes, vascular prostheses should be assessed with regard to complement activation.

摘要

本研究采用C3a、C4a和C5a检测以及体内外交叉免疫电泳法,旨在确定血管假体是否激活补体系统。同时还研究了补体激活的程度和激活途径。测量了不同动脉疾病中的补体水平(C3、C4、CH50),并调查了闭塞性动脉硬化症(ASO)患者补体水平与血脂的关系,以阐明补体系统与动脉硬化或其他动脉疾病之间的关系。牛移植血管、涤纶和聚四氟乙烯在体外激活补体系统。按补体激活程度排序,牛移植血管居首,其次是涤纶和聚四氟乙烯。急性动脉闭塞患者组的C3和C4水平较高。健康老年组的C3和C4水平高于20多岁的健康人群。在ASO患者中,C3水平与血脂水平相关。从血管假体激活补体与动脉硬化变化进展的关系判断,应评估血管假体的补体激活情况。

相似文献

1
Complement activation by vascular prostheses and its role in progression of arteriosclerotic lesions.血管假体的补体激活及其在动脉粥样硬化病变进展中的作用。
Angiology. 1988 Oct;39(10):881-90. doi: 10.1177/000331978803901005.
2
The effects of aortic reconstruction and collagen impregnation of Dacron prostheses on the complement system.主动脉重建及涤纶人工血管胶原浸渍对补体系统的影响。
J Vasc Surg. 1992 Nov;16(5):774-83.
3
Complement activation by synthetic vascular prostheses.合成血管假体引发的补体激活。
J Vasc Surg. 1984 Nov;1(6):829-38.
4
Complement activation produced by biomaterials.生物材料引发的补体激活。
ASAIO Trans. 1986 Jul-Sep;32(1):226-32.
5
C3, C5 components and C3a, C4a, and C5a fragments of the complement system.补体系统的C3、C5成分以及C3a、C4a和C5a片段。
Methods Enzymol. 1988;162:579-625. doi: 10.1016/0076-6879(88)62104-5.
6
Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.变应原激活人血清补体。I. C3a、C4a和C5a的产生以及人中性粒细胞聚集的诱导。
J Allergy Clin Immunol. 1987 Jul;80(1):24-32. doi: 10.1016/s0091-6749(87)80186-0.
7
Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).补体介导的免疫沉淀抑制和溶解作用产生不同浓度的补体过敏毒素(C4a、C3a、C5a)。
Clin Exp Immunol. 1986 May;64(2):407-14.
8
Polyacrylonitrile complement activation attenuated by simultaneous ultrafiltration and adsorption.通过同步超滤和吸附减轻聚丙烯腈补体激活。
Nephrol Dial Transplant. 1987;2(4):251-3.
9
Complement system is not activated in primary biliary cirrhosis.补体系统在原发性胆汁性肝硬化中未被激活。
Clin Immunol Immunopathol. 1998 Jun;87(3):297-303. doi: 10.1006/clin.1998.4542.
10
Complement cleavage products in the phototoxic reaction of porphyria cutanea tarda.迟发性皮肤卟啉症光毒性反应中的补体裂解产物
Br J Dermatol. 1986 May;114(5):567-73. doi: 10.1111/j.1365-2133.1986.tb04063.x.